Mission Statement, Vision, & Core Values (2026) of Medacta Group SA.

From its founding in 1999 to its presence in over 60 countries, Medacta Group SA has built a global reputation-anchored in its Swiss production hubs in Castel San Pietro and Rancate-for transforming orthopedic and spine care through minimally invasive techniques, surgeon partnerships, and a relentless focus on personalized solutions; the company's mission to develop advanced surgical approaches, implants and instruments through responsible innovation is mirrored by a vision to enable healthy, active lives worldwide while prioritizing healthcare sustainability, and its #beMedacta culture-Trust and Integrity, Efficient Execution, Patient and Customer Focus, Sustainable Innovation and Teamwork-drives investments in medical education, collaborative research with universities and the continuous refinement of products and processes that put patient outcomes and environmental responsibility at the forefront.

Medacta Group SA (0A05.L) - Intro

• Global footprint: active in over 60 countries with direct subsidiaries and distribution partners.
• Manufacturing & HQ: main production facilities and corporate offices in Castel San Pietro and Rancate, Switzerland.
• Workforce: approximately 1,600-1,800 employees worldwide (clinical, manufacturing, R&D, commercial and support staff).
• Clinical partnerships: ongoing collaborations with surgeons, universities and OR teams to co-develop techniques, implants and instrumentation.

• Mission: improve patient outcomes and surgeon experience by delivering minimally invasive, evidence-driven and personalized orthopedic solutions.
• Vision: enable better mobility and quality of life worldwide through continuous innovation, education and scalable surgical technologies.
• Core values: patient centricity, clinical collaboration, responsible innovation, quality manufacturing, sustainability and medical education.

• Founded: 1999
• Presence: >60 countries
• Employees: ~1,600-1,800 (global)
• R&D intensity: typically in the mid-single-digit to high-single-digit percentage of revenue (company target range ~6-10%)
• Clinical investments: hundreds of educational events annually and growing digital/virtual training offerings

• Minimally invasive hip and knee systems designed to reduce soft tissue trauma and accelerate recovery; adoption contributing to shorter hospital stays in collaborating centers.
• Personalized solutions (patient-specific instrumentation and workflow) reducing intraoperative variability and improving implant alignment metrics in published clinical series.
• Extensive surgeon-led education programs that drive procedure standardization and data collection for continuous improvement.

• Energy and waste reduction initiatives on production sites in Switzerland; continuous monitoring of environmental KPIs.
• Safety and training programs for manufacturing and clinical partners to lower incident rates and improve outcomes.
• Engagement with academic institutions to support research aligned with public health and global development goals.

• Partnership model: co-development with leading surgeons and academic centers to translate clinical needs into implant and instrumentation design.
• Education: structured courses, proctorships and digital curricula that increase surgeon proficiency and collect outcome data.
• Evidence generation: registry participation and investigator-initiated studies to validate clinical and economic benefits of Medacta solutions.

Medacta Group SA (0A05.L) - Overview

• Collaborative innovation with surgeons and universities worldwide to refine surgical techniques and optimize outcomes for patients.
• Investment in medical education (Medacta Academy) to ensure healthcare professionals are trained on the latest techniques and product use.
• Responsible innovation that integrates sustainability principles and a focus on patient safety and long-term well‑being.
• Personalized solutions (patient‑matched implants and preoperative planning tools) to tailor treatments and improve recovery and quality of life.
• Continuous improvement culture-iterative product development driven by clinical feedback and outcomes data.

• Surgeon co‑development programs: clinicians collaborate on implant design and surgical technique refinement, driving evidence‑based iterations.
• Education metrics: structured curricula with measurable competency outcomes, proctoring hours and case follow‑up to ensure technique adoption.
• Personalization pipeline: patient‑matched guides and preoperative planning tools that reduce operative time and improve implant positioning.
• Sustainability efforts: manufacturing efficiency improvements, waste reduction initiatives, and lifecycle considerations in product design.

• Expand surgeon and academic partnerships to accelerate clinically validated innovations.
• Scale Medacta Academy offerings (in‑person and virtual) to increase global reach and procedural consistency.
• Invest in digital planning, patient‑matched solutions, and outcome tracking to demonstrate value and personalize care.
• Balance growth and margin by investing in high‑value product lines while managing manufacturing and distribution efficiencies.

Medacta Group SA (0A05.L) - Mission Statement

• Global patient focus: making advanced orthopedic and spine solutions accessible in 100+ countries.
• Clinical empowerment: comprehensive education programs for surgeons, teams and hospitals.
• Sustainable innovation: designing products and processes with environmental and social impacts in mind.
• Evidence & outcomes: promoting research and registries to measure and improve patient results.

• Patient-centered outcomes and reduced recovery times through minimally invasive and personalized implants.
• Training and proctoring: expanding surgeon education to scale best practices and reduce variability in outcomes.
• Environmental stewardship: lowering supply‑chain and device lifecycle footprints while preserving clinical performance.

• Excellence - clinical rigor, continuous improvement, and outcome measurement.
• Collaboration - partnerships with surgeons, hospitals, universities and industry stakeholders.
• Integrity - ethical product development, transparent data and patient safety first.
• Innovation - investment in R&D to bring differentiated solutions to market.
• Accessibility - expanding global reach and affordability to serve diverse patient populations.

• Medical education programs-with cadaver labs, digital curricula and proctorship-target scaling best practices and reducing complications.
• Product portfolio strategy that integrates implants, instrumentation and navigation/digital planning to improve reproducibility of outcomes.
• Clinical evidence generation and registry participation to quantify patient benefit and inform iterative product improvements.
• Sustainability initiatives aimed at supply‑chain optimization, recyclable packaging and lower device lifecycle emissions.

Medacta Group SA (0A05.L) - Vision Statement

• Commitment to patients: improve outcomes, reduce recovery times, and expand access to best-in-class treatments.
• Commitment to clinicians: provide reproducible, evidence-based solutions and continuous training through MySchool and educational programs.
• Commitment to sustainable growth: balance cutting‑edge innovation with operational efficiency and responsible resource use.

• Trust and Integrity - uphold the highest ethical and regulatory standards across clinical research, manufacturing, and commercial interactions.
• Efficient Execution - take ownership and deliver measurable results with speed and discipline, optimising costs and timelines.
• Patient and Customer Focused - prioritise patient safety and clinician needs; respond with urgency and dedication to feedback and real-world outcomes.
• Sustainable Innovation - invest in continuous improvement of implants, navigation, robotics, and digital tools to create durable clinical and economic value.
• Teamwork - foster collaboration across R&D, clinical, manufacturing, and commercial teams to scale solutions globally and respectfully.

• Clinical evidence & training - expanding MySchool educational footprint to translate R&D into reproducible surgeon skills and improved patient outcomes.
• Product ecosystem - integrating implants, instruments, and digital navigation to reduce variability and optimise implant positioning.
• Sustainability & manufacturing - investing in efficient production practices and supply-chain resilience to support global access while controlling costs.
• Customer feedback loop - using real-world data and registry collaborations to refine products and demonstrate value to payors and hospitals.